ARCHIVES

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

This article is from The Cancer Letter archive.

Vol. 14 No. 37 | September 23, 1988

Download PDF Visit The Full Archive

Related Articles

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

Straus asks to “Set Record Straight”

September 2, 1988

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989

Salick Raises Nearly $50 Million, Proceeding With FCC Development

June 6, 1986

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998